After its participation on February 7, 2018 in the 3rd International Biotechnology Meetings organized by LEEM and BpiFrance, GlioCure was again selected to present GC01, its new generation anti-glioblastoma peptide, to a panel of European investors during the France Tech Transfer Invest 2018 which will be held on February 13 and 14 at the BpiFrance Hub 8 boulevard Haussmann in Paris 9ème
The event, jointly organized by Tech Tour, the SATT network, BPI France and EuroQuity, will feature 40 start-ups accompanied by the SATT network, including 10 from the biotechnology sector.